Related Experiment Video
Updated: Jun 11, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization
Jayanth Kumar Palanichamy1, Mohit Mehndiratta, Mohita Bhagat
1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India.
Abstract:
Double-stranded RNAs or small interfering RNAs (siRNA) targeting the promoters of genes are known to cause gene knockdown by a process known as transcriptional gene silencing (TGS). We screened multiple siRNAs homologous to one of the NF-1 binding sites in the human papillomavirus-16 (HPV-16) enhancer and identified one siRNA which causes specific TGS of the HPV-16 oncogenes E6 and E7 when transfected into two HPV-16-positive cell lines siHa and CaSki. This phenomenon was specific to the HPV-16 enhancer with no effect on the HPV-18 enhancer. TGS was associated with heterochromatization of the targeted region of the enhancer but no DNA methylation was noted during the time period studied. The choice of target in the enhancer was important as siRNAs differing by one or two bases showed no suppression of downstream gene expression. A low copy number enhancer-associated transcript was detected in the cell lines studied and its level decreased significantly after treatment with the siRNA that caused TGS. This supports the RNA:RNA model described previously for TGS. This siRNA which causes simultaneous silencing of E6 as well as E7 oncogenes by an epigenetic mechanism might be useful as a therapeutic modality for HPV-16-positive cervical and other epithelial cancers.
Insights
Small interfering RNAs (siRNA) can induce transcriptional gene silencing (TGS) by targeting gene promoters. A specific siRNA effectively silenced human papillomavirus-16 (HPV-16) oncogenes E6 and E7 epigenetically, showing therapeutic potential.
Area of Science:
- Molecular Biology
- Epigenetics
- Virology
Background:
- Transcriptional gene silencing (TGS) is a process where double-stranded or small interfering RNAs (siRNA) targeting gene promoters reduce gene expression.
- Human papillomavirus-16 (HPV-16) is associated with cervical and other epithelial cancers, driven by oncogenes E6 and E7.
Purpose of the Study:
- To identify and characterize siRNAs capable of inducing TGS specifically in HPV-16-positive cells.
- To investigate the mechanism and specificity of TGS targeting the HPV-16 enhancer.
Main Methods:
- Screening of multiple siRNAs targeting an NF-1 binding site in the HPV-16 enhancer.
- Transfection of siRNAs into HPV-16-positive cell lines (siHa and CaSki).
- Analysis of gene expression, heterochromatization, DNA methylation, and enhancer-associated transcripts.
Main Results:
- One specific siRNA induced TGS of HPV-16 oncogenes E6 and E7 in HPV-16-positive cell lines.
- The TGS was specific to the HPV-16 enhancer and associated with heterochromatization.
- A decrease in an enhancer-associated transcript supported the RNA:RNA model for TGS.
Conclusions:
- A specific siRNA can epigenetically silence HPV-16 E6 and E7 oncogenes via TGS.
- This siRNA demonstrates specificity for the HPV-16 enhancer, not affecting HPV-18.
- The findings suggest a potential therapeutic strategy for HPV-16-associated cancers.
Related Concept Videos
Experimental RNAi
Inheritance of Chromatin Structures
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Position-effect Variegation

